emm1 and emm3 infections are acknowledged to be associated with increased risk of severe outcomes and mortality compared with other emm genotypes, although most large-scale population-based epidemiological studies were undertaken prior to iGAS being notifiable in England, and prior to the emergence of M1UK [2, 22]. This evidence concerns the gene PIGG and infection.